PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2148900
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2148900
In Vitro Fertilization Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
Growth Factors of in vitro fertilization (IVF) Market
The global in vitro fertilization (IVF) market is witnessing strong expansion due to the rising prevalence of infertility, increasing awareness of assisted reproductive technologies, delayed pregnancies, and improvements in IVF treatment success rates. According to the report, the global IVF market size was valued at USD 28.97 billion in 2025 and is projected to reach USD 30.99 billion in 2026 and USD 53.25 billion by 2034. The market is expected to expand at a CAGR of 7.00% from 2026 to 2034.
IVF is one of the most widely adopted assisted reproductive technologies (ART). The procedure involves retrieving eggs, collecting sperm, and combining them in a laboratory before transferring the resulting embryo into the uterus. The growing adoption of IVF and intracytoplasmic sperm injection (ICSI) is creating significant opportunities for fertility clinics, hospitals, medical technology providers, and reproductive healthcare organizations.
Europe dominated the global IVF market with a 44.82% market share in 2025, supported by increasing infertility rates, advanced fertility infrastructure, and improving IVF success rates.
In Vitro Fertilization Market Trends
A major IVF market trend is the increasing adoption of advanced fertility procedures, particularly IVF combined with ICSI. ICSI has become an important treatment option for male infertility and is contributing to the expansion of advanced reproductive healthcare services.
Another significant trend is the increasing age of first-time pregnancy. Career priorities, delayed marriages, financial considerations, and changing lifestyles are encouraging couples to postpone family planning. As fertility generally declines with age, delayed pregnancies are contributing to greater demand for fertility treatment.
However, the high cost and potential risks associated with IVF and ICSI procedures remain important market restraints. Concerns regarding treatment-related complications and potential birth-related risks can influence patient decisions and limit adoption in some markets.
In Vitro Fertilization Market Drivers
Rising Prevalence of Infertility: Increasing infertility among both women and men is one of the strongest factors supporting IVF market growth. Lifestyle changes, obesity, stress, and sedentary habits are further contributing to infertility rates.
Delayed Pregnancy: Increasing maternal age at first pregnancy is creating greater demand for assisted reproductive technologies. Couples delaying childbirth because of professional and financial priorities are increasingly seeking fertility treatments.
Improving IVF Success Rates: Technological improvements in embryo development, laboratory procedures, fertility testing, and ICSI are improving treatment outcomes and encouraging wider adoption.
Government Support and Reimbursement: Improvements in healthcare infrastructure and reimbursement initiatives in selected countries are helping increase access to IVF treatment.
Market Restraints and Challenges
The high cost of IVF treatment is a major challenge, particularly in countries where fertility procedures receive limited reimbursement. Treatment may also require multiple cycles, increasing the overall financial burden for patients.
Potential medical risks, treatment complications, stringent regulations related to donor eggs and sperm, and limited availability of specialized fertility professionals can also restrict market expansion. In addition, IVF requires specialized laboratories, equipment, trained embryologists, and experienced medical professionals.
In Vitro Fertilization Market Segmentation Analysis
By Type: The market is segmented into conventional IVF and IVF with ICSI. IVF with ICSI represents a major segment because of its widespread application in male infertility treatment. Conventional IVF is also expected to maintain significant demand because of its comparatively lower procedural complexity and cost.
By Procedure: The market includes fresh non-donor, frozen non-donor, fresh donor, and frozen donor procedures. Fresh non-donor procedures benefit from demand for fresh eggs and embryos, while frozen non-donor procedures are supported by comparatively lower treatment costs. Donor-based procedures face regulatory restrictions in several countries.
By End User: The market is divided into fertility clinics and hospitals. Fertility clinics dominate because they provide specialized reproductive services, dedicated IVF infrastructure, and experienced medical teams. Hospitals hold a comparatively smaller share due to limited IVF specialization and reimbursement-related challenges.
Regional Analysis
Europe: Europe held the largest market share of 44.82% in 2025 and generated USD 7.57 billion in 2026. Spain and Denmark are among the active IVF markets in the region, supported by established fertility services and improving treatment success rates.
North America: North America is projected to experience steady growth. High IVF treatment costs remain a challenge, but increasing infertility awareness and demand for advanced reproductive technologies continue to support the market.
Asia Pacific: Asia Pacific is expected to register the fastest growth through 2034. Increasing infertility awareness, expanding fertility clinics, improving healthcare infrastructure, and medical tourism are contributing to market opportunities across the region. Japan and Australia are notable markets within the region.
Latin America and Middle East & Africa: These regions are expected to witness increasing adoption as healthcare infrastructure develops and medical tourism for infertility treatment expands.
Key Industry Players
Major companies and fertility service providers include Boston IVF, Monash IVF, Pelargos IVF, Ovation Fertility, RSMC, Shady Grove Fertility, Group Ambroise Pare Clinic, Bangkok IVF Center, and Bloom IVF Centre. These providers are focusing on specialized fertility services, advanced reproductive technologies, embryo screening, and improved patient care.
Recent Industry Developments
Shady Grove Fertility announced the opening of a new full-service IVF center in Tampa, Florida. Scientists at Monash IVF developed an embryo screening test aimed at reducing miscarriage risks during IVF treatment. NMC Health plc also acquired a majority stake in Boston IVF to expand its fertility healthcare network.
Conclusion
The in vitro fertilization market is positioned for sustained growth as infertility prevalence increases and more couples seek assisted reproductive technologies. The global market is valued at USD 28.97 billion in 2025, rising to USD 30.99 billion in 2026 and projected to reach USD 53.25 billion by 2034. Europe remains the leading regional market, while Asia Pacific is expected to deliver the fastest growth. Increasing adoption of ICSI, improved IVF success rates, delayed pregnancies, expanding fertility clinics, and technological advancements will remain important factors shaping the IVF market outlook through 2034.
Unit Value (USD billion)
Segmentation By Type
- Conventional IVF
- IVF with ICSI
By Procedure
- Fresh Non-donor
- Frozen Non-donor
- Fresh Donor
- Frozen Donor
By End User
- Hospitals
- Fertility Clinics
By Geography
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and the Rest of Latin America)
- Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Prevalence of Infertility, For Key Country/Region, 2025
- 4.2. Number of IVF Procedures, For Key Country/Regions, 2025
- 4.3. Number of Registered Fertility Clinics, For Key Countries, 2025
- 4.4. Reimbursement Scenario, For Key Country/Region
- 4.5. Key Industry Developments, Partnerships, Mergers and Acquisition
5. Global In Vitro Fertilization (IVF) Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast - By Type
- 5.2.1. Conventional IVF
- 5.2.2. IVF with ICSI
- 5.3. Market Analysis, Insights and Forecast - By Procedure
- 5.3.1. Fresh Non-donor
- 5.3.2. Frozen Non-donor
- 5.3.3. Fresh Donor
- 5.3.4. Frozen Donor
- 5.4. Market Analysis, Insights and Forecast - By End User
- 5.4.1. Hospitals
- 5.4.2. Fertility Clinics
- 5.5. Market Analysis, Insights and Forecast - By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America In Vitro Fertilization (IVF) Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast - By Type
- 6.2.1. Conventional IVF
- 6.2.2. IVF with ICSI
- 6.3. Market Analysis, Insights and Forecast - By Procedure
- 6.3.1. Fresh Non-donor
- 6.3.2. Frozen Non-donor
- 6.3.3. Fresh Donor
- 6.3.4. Frozen Donor
- 6.4. Market Analysis, Insights and Forecast - By End User
- 6.4.1. Hospitals
- 6.4.2. Fertility Clinics
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe In Vitro Fertilization (IVF) Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast - By Type
- 7.2.1. Conventional IVF
- 7.2.2. IVF with ICSI
- 7.3. Market Analysis, Insights and Forecast - By Procedure
- 7.3.1. Fresh Non-donor
- 7.3.2. Frozen Non-donor
- 7.3.3. Fresh Donor
- 7.3.4. Frozen Donor
- 7.4. Market Analysis, Insights and Forecast - By End User
- 7.4.1. Hospitals
- 7.4.2. Fertility Clinics
- 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia pacific In Vitro Fertilization (IVF) Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast - By Type
- 8.2.1. Conventional IVF
- 8.2.2. IVF with ICSI
- 8.3. Market Analysis, Insights and Forecast - By Procedure
- 8.3.1. Fresh Non-donor
- 8.3.2. Frozen Non-donor
- 8.3.3. Fresh Donor
- 8.3.4. Frozen Donor
- 8.4. Market Analysis, Insights and Forecast - By End User
- 8.4.1. Hospitals
- 8.4.2. Fertility Clinics
- 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America In Vitro Fertilization (IVF) Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast - By Type
- 9.2.1. Conventional IVF
- 9.2.2. IVF with ICSI
- 9.3. Market Analysis, Insights and Forecast - By Procedure
- 9.3.1. Fresh Non-donor
- 9.3.2. Frozen Non-donor
- 9.3.3. Fresh Donor
- 9.3.4. Frozen Donor
- 9.4. Market Analysis, Insights and Forecast - By End User
- 9.4.1. Hospitals
- 9.4.2. Fertility Clinics
- 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa In Vitro Fertilization (IVF) Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast - By Type
- 10.2.1. Conventional IVF
- 10.2.2. IVF with ICSI
- 10.3. Market Analysis, Insights and Forecast - By Procedure
- 10.3.1. Fresh Non-donor
- 10.3.2. Frozen Non-donor
- 10.3.3. Fresh Donor
- 10.3.4. Frozen Donor
- 10.4. Market Analysis, Insights and Forecast - By End User
- 10.4.1. Hospitals
- 10.4.2. Fertility Clinics
- 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.5.1. GCC Countries
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2025)
- 11.3. Company Profiles
- 11.3.1. Boston IVF
- 11.3.1.1. Overview,
- 11.3.1.2. Services,
- 11.3.1.3. SWOT Analysis,
- 11.3.1.4. Recent Developments,
- 11.3.1.5. Strategies,
- 11.3.1.6. Financials (Based on Availability)
- 11.3.2. Monash IVF
- 11.3.2.1. Overview,
- 11.3.2.2. Services,
- 11.3.2.3. SWOT Analysis,
- 11.3.2.4. Recent Developments,
- 11.3.2.5. Strategies,
- 11.3.2.6. Financials (Based on Availability)
- 11.3.3. Pelargos IVF
- 11.3.3.1. Overview,
- 11.3.3.2. Services,
- 11.3.3.3. SWOT Analysis,
- 11.3.3.4. Recent Developments,
- 11.3.3.5. Strategies,
- 11.3.3.6. Financials (Based on Availability)
- 11.3.4. Ovation Fertility
- 11.3.4.1. Overview,
- 11.3.4.2. Services,
- 11.3.4.3. SWOT Analysis,
- 11.3.4.4. Recent Developments,
- 11.3.4.5. Strategies,
- 11.3.4.6. Financials (Based on Availability)
- 11.3.5. RSMC
- 11.3.5.1. Overview,
- 11.3.5.2. Services,
- 11.3.5.3. SWOT Analysis,
- 11.3.5.4. Recent Developments,
- 11.3.5.5. Strategies,
- 11.3.5.6. Financials (Based on Availability)
- 11.3.6. Shady Grove Fertility
- 11.3.6.1. Overview,
- 11.3.6.2. Services,
- 11.3.6.3. SWOT Analysis,
- 11.3.6.4. Recent Developments,
- 11.3.6.5. Strategies,
- 11.3.6.6. Financials (Based on Availability)
- 11.3.7. Group Ambroise Pare Clinic
- 11.3.7.1. Overview,
- 11.3.7.2. Services,
- 11.3.7.3. SWOT Analysis,
- 11.3.7.4. Recent Developments,
- 11.3.7.5. Strategies,
- 11.3.7.6. Financials (Based on Availability)
- 11.3.8. Bangkok IVF center
- 11.3.8.1. Overview,
- 11.3.8.2. Services,
- 11.3.8.3. SWOT Analysis,
- 11.3.8.4. Recent Developments,
- 11.3.8.5. Strategies,
- 11.3.8.6. Financials (Based on Availability)
- 11.3.9. Bloom IVF Centre
- 11.3.9.1. Overview,
- 11.3.9.2. Services,
- 11.3.9.3. SWOT Analysis,
- 11.3.9.4. Recent Developments,
- 11.3.9.5. Strategies,
- 11.3.9.6. Financials (Based on Availability)
- 11.3.10. Other Players
- 11.3.10.1. Overview,
- 11.3.10.2. Services,
- 11.3.10.3. SWOT Analysis,
- 11.3.10.4. Recent Developments,
- 11.3.10.5. Strategies,
- 11.3.10.6. Financials (Based on Availability)
- 11.3.1. Boston IVF
12. Strategic Recommendations
List of Tables
- Table 1: Global In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
- Table 2: Global In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by Procedure, 2021-2034
- Table 3: Global In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
- Table 4: Global In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by Region, 2021-2034
- Table 5: North America In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
- Table 6: North America In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by Procedure, 2021-2034
- Table 7: North America In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
- Table 8: North America In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, By Country, 2021-2034
- Table 9: Europe In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
- Table 10: Europe In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by Procedure, 2021-2034
- Table 11: Europe In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
- Table 12: Europe In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
- Table 13: Asia Pacific In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
- Table 14: Asia Pacific In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by Procedure, 2021-2034
- Table 15: Asia Pacific In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
- Table 16: Asia Pacific In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
- Table 17: Latin America In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
- Table 18: Latin America In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by Procedure, 2021-2034
- Table 19: Latin America In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
- Table 20: Latin America In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
- Table 21: Middle East & Africa In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
- Table 22: Middle East & Africa In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by Procedure, 2021-2034
- Table 23: Middle East & Africa In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
- Table 24: Middle East & Africa In Vitro Fertilization (IVF) Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global In Vitro Fertilization (IVF) Market Revenue Breakdown (US$ Mn, %) by Region, 2025 & 2034
- Figure 2: Global In Vitro Fertilization (IVF) Market Value Share (%), by Type, 2025 & 2034
- Figure 3: Global In Vitro Fertilization (IVF) Market Value Share (%), by Procedure, 2025 & 2034
- Figure 4: Global In Vitro Fertilization (IVF) Market Value Share (%), by Modality, 2025 & 2034
- Figure 5: Global In Vitro Fertilization (IVF) Market Value Share (%), by End-user, 2025 & 2034
- Figure 6: Global In Vitro Fertilization (IVF) Market Value (US$ Mn), by Region, 2025 & 2034
- Figure 7: North America In Vitro Fertilization (IVF) Market Value (US$ Mn), by Type, 2025 & 2034
- Figure 8: North America In Vitro Fertilization (IVF) Market Value Share (%), by Type, 2025
- Figure 9: North America In Vitro Fertilization (IVF) Market Value (US$ Mn), by Procedure, 2025 & 2034
- Figure 10: North America In Vitro Fertilization (IVF) Market Value Share (%), by Procedure, 2025
- Figure 11: North America In Vitro Fertilization (IVF) Market Value (US$ Mn), by End-user, 2025 & 2034
- Figure 12: North America In Vitro Fertilization (IVF) Market Value Share (%), by End-user, 2025
- Figure 13: North America In Vitro Fertilization (IVF) Market Value (US$ Mn), By Country, 2025 & 2034
- Figure 14: North America In Vitro Fertilization (IVF) Market Value Share (%), By Country, 2025
- Figure 15: Europe In Vitro Fertilization (IVF) Market Value (US$ Mn), by Type, 2025 & 2034
- Figure 16: Europe In Vitro Fertilization (IVF) Market Value Share (%), by Type, 2025
- Figure 17: Europe In Vitro Fertilization (IVF) Market Value (US$ Mn), by Procedure, 2025 & 2034
- Figure 18: Europe In Vitro Fertilization (IVF) Market Value Share (%), by Procedure, 2025
- Figure 19: Europe In Vitro Fertilization (IVF) Market Value (US$ Mn), by End-user, 2025 & 2034
- Figure 20: Europe In Vitro Fertilization (IVF) Market Value Share (%), by End-user, 2025
- Figure 21: Europe In Vitro Fertilization (IVF) Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
- Figure 22: Europe In Vitro Fertilization (IVF) Market Value Share (%), By Country/ Sub-region, 2025
- Figure 23: Asia Pacific In Vitro Fertilization (IVF) Market Value (US$ Mn), by Type, 2025 & 2034
- Figure 24: Asia Pacific In Vitro Fertilization (IVF) Market Value Share (%), by Type, 2025
- Figure 25: Asia Pacific In Vitro Fertilization (IVF) Market Value (US$ Mn), by Procedure, 2025 & 2034
- Figure 26: Asia Pacific In Vitro Fertilization (IVF) Market Value Share (%), by Procedure, 2025
- Figure 27: Asia Pacific In Vitro Fertilization (IVF) Market Value (US$ Mn), by End-user, 2025 & 2034
- Figure 28: Asia Pacific In Vitro Fertilization (IVF) Market Value Share (%), by End-user, 2025
- Figure 29: Asia Pacific In Vitro Fertilization (IVF) Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
- Figure 30: Asia Pacific In Vitro Fertilization (IVF) Market Value Share (%), By Country/ Sub-region, 2025
- Figure 31: Latin America In Vitro Fertilization (IVF) Market Value (US$ Mn), by Type, 2025 & 2034
- Figure 32: Latin America In Vitro Fertilization (IVF) Market Value Share (%), by Type, 2025
- Figure 33: Latin America In Vitro Fertilization (IVF) Market Value (US$ Mn), by Procedure, 2025 & 2034
- Figure 34: Latin America In Vitro Fertilization (IVF) Market Value Share (%), by Procedure, 2025
- Figure 35: Latin America In Vitro Fertilization (IVF) Market Value (US$ Mn), by End-user, 2025 & 2034
- Figure 36: Latin America In Vitro Fertilization (IVF) Market Value Share (%), by End-user, 2025
- Figure 37: Latin America In Vitro Fertilization (IVF) Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
- Figure 38: Latin America In Vitro Fertilization (IVF) Market Value Share (%), By Country/ Sub-region, 2025
- Figure 39: Middle East & Africa In Vitro Fertilization (IVF) Market Value (US$ Mn), by Type, 2025 & 2034
- Figure 40: Middle East & Africa In Vitro Fertilization (IVF) Market Value Share (%), by Type, 2025
- Figure 41: Middle East & Africa In Vitro Fertilization (IVF) Market Value (US$ Mn), by Procedure, 2025 & 2034
- Figure 42: Middle East & Africa In Vitro Fertilization (IVF) Market Value Share (%), by Procedure, 2025
- Figure 43: Middle East & Africa In Vitro Fertilization (IVF) Market Value (US$ Mn), by End-user, 2025 & 2034
- Figure 44: Middle East & Africa In Vitro Fertilization (IVF) Market Value Share (%), by End-user, 2025
- Figure 45: Middle East & Africa In Vitro Fertilization (IVF) Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
- Figure 46: Middle East & Africa In Vitro Fertilization (IVF) Market Value Share (%), By Country/ Sub-region, 2025
- Figure 47: Global In Vitro Fertilization (IVF) Market Share (%), By Company, 2025
